Haleon will target greater household penetration

3 March 2022 - Deborah Wilkes

Premium

Increasing household penetration for its brands will be the “largest opportunity” for GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, according to Brian McNamara, chief executive officer designate of Haleon.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: